ANALYSIS: As Vital Healthcare revives a restructuring scheme, directors of its external manager seem particularly antsy about their independence.
The Nasdaq-listed parent company is a hot mess of dodgy finances and vague disclosures.
No-one should be surprised by high power prices when lakes are low.
After a turbulent start, the regulator has been adept at avoiding conflict.
Shareholders get scant detail on a big management contract deal.
The surprise attack on interest deductibility highlights the emptiness of economic orthodoxy.
A2 Milk’s NZX statement on the exit of Jayne Hrdlicka was false, so what else don’t we know?
A fund manager’s zero fee claim is not what it seems.
They didn’t take off in NZ but cashed-up shells are all the rage in the US.
A share buyback at Rural Equities offers shareholders an uncomfortable choice.
